Systemic sclerosis, breast cancer and calcium channel blockers: A new player on the scene?

Autoimmunity Reviews

Volumn 13, Issue 8, 2014, Pages 880-881

  Bernal Bello, D ^a   Garcia de Tena J ^a   Simeon Aznar C ^b   Fonollosa Pla, V ^b  

^a HOSPITAL UNIVERSITARIO DE GUADALAJARA   (Spain)

^b HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

Apoptosis; Breast cancer; Calcium channel blockers; Raynaud's phenomenon; Scleroderma; Systemic sclerosis

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT;

APOPTOSIS; BREAST CANCER; DISEASE DURATION; HUMAN; LETTER; PHAGOCYTOSIS; RADIATION EXPOSURE; SCLERODERMA; SMOKING; SYSTEMIC SCLEROSIS;

APOPTOSIS; BREAST CANCER; CALCIUM CHANNEL BLOCKERS; RAYNAUD'S PHENOMENON; SCLERODERMA; SYSTEMIC SCLEROSIS;

BREAST NEOPLASMS; FEMALE; HUMANS; MALE; SCLERODERMA, SYSTEMIC;

EID: 84902126170     PISSN: 15689972     EISSN: 18730183     Source Type: Journal    
DOI: 10.1016/j.autrev.2014.03.003     Document Type: Letter

References (28)

1. LeRoy E.C., Black C., Fleischmajer R., Jablonska S., Krieg T., Medsger T.A., et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988, 15:202-205.
2. Herrick A.L. The pathogenesis, diagnosis and treatment of Raynaud phenomenon. Nat Rev Rheumatol 2012, 8:469-479.
3. Meier F.M., Frommer K.W., Dinser R., Walker U.A., Czirjak L., Denton C.P., et al. Update on the profile of the EUSTAR cohort: an analysis of the EULAR Scleroderma Trials and Research group database. Ann Rheum Dis 2012, 71:1355-1360.
4. Prete M., Fatone M.C., Favoino E., Perosa F. Raynaud's phenomenon: from molecular pathogenesis to therapy. Autoimmun Rev Jan. 10 2014, 13:655-667.
5. Thompson A.E., Shea B., Welch V., Fenlon D., Pope J.E. Calcium-channel blockers for Raynaud's phenomenon in systemic sclerosis. Arthritis Rheum 2001, 44:1841-1847.
6. Kowal-Bielecka O., Landewe R., Avouac J., Chwiesko S., Miniati I., Czirjak L., et al. EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR). Ann Rheum Dis 2009, 68:620-628.
7. Allanore Y., Meune C., Vonk M.C., Airo P., Hachulla E., Caramaschi P., et al. Prevalence and factors associated with left ventricular dysfunction in the EULAR Scleroderma Trial and Research group (EUSTAR) database of patients with systemic sclerosis. Ann Rheum Dis 2010, 69:218-221.
8. Desai C.S., Lee D.C., Shah S.J. Systemic sclerosis and the heart: current diagnosis and management. Curr Opin Rheumatol 2011, 23:545-554.
9. Fitzpatrick A.L., Daling J.R., Furberg C.D., Kronmal R.A., Weissfeld J.L. Use of calcium channel blockers and breast carcinoma risk in postmenopausal women. Cancer 1997, 80:1438-1447.
10. Li C.I., Malone K.E., Weiss N.S., Boudreau D.M., Cushing-Haugen K.L., Daling J.R. Relation between use of antihypertensive medications and risk of breast carcinoma among women ages 65-79 years. Cancer 2003, 98:1504-1513.
11. Fryzek J.P., Poulsen A.H., Lipworth L., Pedersen L., Nørgaard M., McLaughlin J.K., et al. A cohort study of antihypertensive medication use and breast cancer among Danish women. Breast Cancer Res Treat 2006, 97:231-236.
12. Jick H., Jick S., Derby L.E., Vasilakis C., Myers M.W., Meier C.R. Calcium-channel blockers and risk of cancer. Lancet 1997, 349:525-528.
13. Rosenberg L., Rao R.S., Palmer J.R., Strom B.L., Stolley P.D., Zauber A.G., et al. Calcium-channel blockers and the risk of cancer. JAMA 1998, 279:1000-1004.
14. Sørensen H.T., Olsen J.H., Mellemkjaer L., Marie A., Steffensen F.H., McLaughlin J.K., et al. Cancer risk and mortality in users of calcium channel blockers: a cohort study. Cancer 2000, 89:165-170.
15. Olsen J.H., Sørensen H.T., Friis S., McLaughlin J.K., Steffensen F.H., Nielsen G.L., et al. Cancer risk in users of calcium channel blockers. Hypertension 1997, 29:1091-1094.
16. Michels K.B., Rosner B.A., Walker A.M., Stampfer M.J., Manson J.E., Colditz G.A., et al. Calcium channel blockers, cancer incidence, and cancer mortality in a cohort of U.S. women: the nurses' health study. Cancer 1998, 83:2003-2007.
17. Meier C.R., Derby L.E., Jick S.S., Jick H. Angiotensin-converting enzyme inhibitors, calcium channel blockers, and breast cancer. Arch Intern Med 2000, 160:349-353.
18. Pahor M., Guralnik J.M., Ferrucci L., Corti M.C., Salive M.E., Cerhan J.R., et al. Calcium-channel blockade and incidence of cancer in aged populations. Lancet 1996, 348:493-497.
19. Li C.I., Daling J.R., Tang M.T., Haugen K.L., Porter P.L., Malone K.E. Use of antihypertensive medications and breast cancer risk among women aged 55 to 74years. JAMA Intern Med 2013, 173:1629-1637.
20. Colaci M., Giuggioli D., Vacchi C., Lumetti F., Iachetta F., Marcheselli L., et al. Breast cancer in systemic sclerosis: results of a cross-linkage of an Italian Rheumatologic Center and a population-based Cancer Registry and review of the literature. Autoimmun Rev 2014, 13:132-137.
21. Yoneda T., Imaizumi K., Oono K., Yui D., Gomi F., Katayama T., et al. Activation of caspase-12, an endoplastic reticulum (ER) resident caspase, through tumor necrosis factor receptor-associated factor 2-dependent mechanism in response to the ER stress. J Biol Chem 2001, 276:13935-13940.
22. Iwasawa R., Mahul-Mellier A.L., Datler C., Pazarentzos E., Grimm S. Fis1 and Bap31 bridge the mitochondria-ER interface to establish a platform for apoptosis induction. EMBO J 2011, 30(3):556-568.
23. Schwab B.L., Guerini D., Didszun C., Bano D., Ferrando-May E., Fava E., et al. Cleavage of plasma membrane calcium pumps by caspases: a link between apoptosis and necrosis. Cell Death Differ 2002, 9:818-831.
24. Wyllie A.H. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 1980, 284:555-556.
25. Szalai G., Krishnamurthy R., Hajnóczky G. Apoptosis driven by IP(3)-linked mitochondrial calcium signals. EMBO J 1999, 18:6349-6361.
26. Suzuki J., Umeda M., Sims P.J., Nagata S. Calcium-dependent phospholipid scrambling by TMEM16F. Nature 2010, 468:834-838.
27. Daling J.R. Calcium channel blockers and cancer: is an association biologically plausible?. Am J Hypertens 1996, 9:713-714.
28. Mason R.P. Calcium channel blockers, apoptosis and cancer: is there a biologic relationship?. J Am Coll Cardiol 1999, 34:1857-1866.